Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Quality Improvement in Acute Ischemic Stroke Care in Taiwan: The Breakthrough Collaborative in Stroke

  • Fang-I Hsieh ,

    Contributed equally to this work with: Fang-I Hsieh, Jiann-Shing Jeng

    Affiliation School of Public Health, Taipei Medical University, Taipei, Taiwan

  • Jiann-Shing Jeng ,

    Contributed equally to this work with: Fang-I Hsieh, Jiann-Shing Jeng

    Affiliation Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan

  • Chang-Ming Chern,

    Affiliation Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

  • Tsong-Hai Lee,

    Affiliation Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Linkou, Taiwan

  • Sung-Chun Tang,

    Affiliation Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan

  • Li-Kai Tsai,

    Affiliation Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan

  • Hsun-Hsiang Liao,

    Affiliation Taiwan Joint Commission on Hospital Accreditation, Taipei, Taiwan

  • Hang Chang,

    Affiliation Taiwan Joint Commission on Hospital Accreditation, Taipei, Taiwan

  • Kenneth A. LaBresh,

    Affiliation RTI International, Waltham, Massachusetts, United States of America

  • Hung-Jung Lin,

    Affiliations Taiwan Joint Commission on Hospital Accreditation, Taipei, Taiwan, Department of Emergency Medicine, Chi-Mei Medical Center, Tainan, Taiwan, Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan

  • Hung-Yi Chiou,

    Affiliation School of Public Health, Taipei Medical University, Taipei, Taiwan

  • Hou-Chang Chiu,

    Affiliations Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, College of Medicine, Fu Jen Catholic University, Taipei, Taiwan

  • Li-Ming Lien ,

    Current address: Department of Neurology, Shin Kong Wu-Ho-Su Memorial Hospital, No 95, Wen Chang Road, Taipei, Taiwan

    Affiliations Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

  • for the BTS-Stroke Investigators

    BTS-Stroke Investigators are provided in the Acknowledgments.

Quality Improvement in Acute Ischemic Stroke Care in Taiwan: The Breakthrough Collaborative in Stroke

  • Fang-I Hsieh, 
  • Jiann-Shing Jeng, 
  • Chang-Ming Chern, 
  • Tsong-Hai Lee, 
  • Sung-Chun Tang, 
  • Li-Kai Tsai, 
  • Hsun-Hsiang Liao, 
  • Hang Chang, 
  • Kenneth A. LaBresh, 
  • Hung-Jung Lin


In the management of acute ischemic stroke, guideline adherence is often suboptimal, particularly for intravenous thrombolysis or anticoagulation for atrial fibrillation. We sought to improve stroke care quality via a collaborative model, the Breakthrough Series (BTS)-Stroke activity, in a nationwide, multi-center activity in Taiwan. A BTS Collaborative, a short-term learning system for a large number of multidisciplinary teams from hospitals, was applied to enhance acute ischemic stroke care quality. Twenty-four hospitals participated in and submitted data for this stroke quality improvement campaign in 2010–2011. Totally, 14 stroke quality measures, adopted from the Get With The Guideline (GWTG)-Stroke program, were used to evaluate the performance and outcome of the ischemic stroke patients. Data for a one-year period from 24 hospitals with 13,181 acute ischemic stroke patients were analyzed. In 14 hospitals, most stroke quality measures improved significantly during the BTS-activity compared with a pre-BTS-Stroke activity period (2006–08). The rate of intravenous thrombolysis increased from 1.2% to 4.6%, door-to-needle time ≤60 minutes improved from 7.1% to 50.8%, symptomatic hemorrhage after intravenous thrombolysis decreased from 11.0% to 5.6%, and anticoagulation therapy for atrial fibrillation increased from 32.1% to 64.1%. The yearly composite measures of five stroke quality measures revealed significant improvements from 2006 to 2011 (75% to 86.3%, p<0.001). The quarterly composite measures also improved significantly during the BTS-Stroke activity. In conclusion, a BTS collaborative model is associated with improved guideline adherence for patients with acute ischemic stroke. GWTG-Stroke recommendations can be successfully applied in countries besides the United States.


It has been estimated that 16 million people suffer a stroke each year worldwide, and that 5.7 million will die as a result; moreover, around half of stroke survivors will suffer permanent disability [1]. Stroke is the leading cause of serious long-term disability in adults, resulting in significant disability-adjusted life year loss [2,3]. Strategies to decrease disability, improve functional outcomes, and prevent stroke recurrence are key aspects of effective acute stroke care. Indeed, many evidence-based stroke care guidelines have been updated in accordance with these considerations to successfully guide clinical practice procedures for stroke or transient ischemic attack [48]. However, with an adherence rate to evidence-based care of only 55% [9], a significant gap still exists between recommended guidelines and actual clinical practice. Adherence to evidence-based guidelines for treatment of stroke or transient ischemic attack is often suboptimal [10,11], and the availability of published recommended clinical guidelines is not in itself sufficient for successful management. Strategies that incorporate educational programs, as well as quality surveys on the implementation of the guidelines in clinical practice, are needed to improve stroke care quality [12].

Stroke performance measures (or stroke metrics) are important for quantifying improvements in the quality of stroke care [13]. Previously, several stroke performance measures have been applied in stroke care quality improvement programs, including the Primary Stroke Center and Comprehensive Stroke Center designation, the Center for Disease Control and Prevention Paul Coverdell National Acute Stroke Registry, the Get With The Guidelines (GWTG)-Stroke program in the United States [1418], the Danish National Indicator Project [19], the Netherlands Stroke Survey [20], and the Catalonia Stroke Program [21]. The Taiwan Stroke Registry (TSR), undertaken from 2006 to 2008, revealed that the GWTG-Stroke performance measures are applicable in Taiwan, and that several performance measures needed to be improved to achieve a standard of care consistent with the GWTG-Stroke program [22]. In accomplishing this, the TSR study emphasized the importance of thrombolytic therapy, as well as anticoagulant treatment for atrial fibrillation (AF) and use of lipid lowering drugs for low density lipoprotein (LDL) ≥100 mg/dL [22].

The Institute for Healthcare Improvement, which seeks to improve health care by supporting process change, conceptualized the Breakthrough Series (BTS)–a model for achieving breakthrough improvements in quality while reducing costs—in 1994 [23,24]. A BTS collaboration is a short-term learning system that brings together a large number of teams from hospitals in order to drive improvements on a focused topic. The present study aimed to demonstrate the improved quality of acute ischemic stroke management via a BTS collaborative learning model in a nationwide, multi-center activity in Taiwan.


The Taiwan BTS-Stroke activity

Since 2006, the Taiwan Joint Commission on Hospital Accreditation has adopted the BTS model to improve healthcare quality in Taiwan for several focused topics. Improvement of acute stroke care quality was the main concern of the Taiwan Joint Commission on Hospital Accreditation in 2010. In May and June of 2010, an expert panel of neurologists, neurosurgeons, emergency medicine specialists, and stroke nursing specialists identified 14 quality measures for effective management and prevention of acute ischemic stroke. A BTS-Stroke activity was conducted from August 2010 to July 2011, in which hospitals with interests in acute stroke care quality improvement were encouraged to participate. Over a one-year period, the BTS-Stroke activity consisted of three learning sessions and a final summative meeting. For each hospital team, three to seven members could attend the learning sessions. The activity followed the key elements of the BTS model, including topic selection, faculty recruitment, enrollment of participating organizations and teams, learning sessions, action periods, improvement of the model, summative congresses and publications, and measurement and evaluation [23,24].

Data collection.

Data used to calculate the BTS-Stroke quality and safety measures were compiled from medical record by trained neurologists and their study nurses or stroke case managers. The definitions of each quality and safety measures were clearly written in the proposal and explained to each participating hospitals in learning sessions. The number of eligible patients and the number of interventions performed were reported to the BTS data center every month from August 2010 to July 2011. Therefore, there were no personal details in all data reported to BTS data center, only the name of hospital was available. Before the data released for statistical analysis, a code number was given instead of the hospital’s name. In this study, ethics approval with waiver of informed consent was provided by the Institutional Review Board of Taipei Medical University.

BTS-Stroke quality measures.

Nine GWTG-Stroke quality measures and one safety measure were used to assess the quality of acute ischemic stroke care and prevention [18]: (1) intravenous tissue plasminogen activator (IV tPA) use in patients who arrived at a participating hospital <2 hours from symptom onset; (2) antithrombotic medication use within 48 hours of admission; (3) discharge prescription of antithrombotics; (4) discharge prescription of oral anticoagulants for AF; (5) prescription of lipid lowering drugs at discharge for LDL ≥100 mg/dL; (6) time of door-to-computed tomography (CT) ≤25 minutes in patients presenting with stroke symptoms of <3 hours duration; (7) dysphagia screening prior to any oral intake; (8) assessment for stroke rehabilitation services; (9) stroke education provided to patient and/or caregiver; and (10) symptomatic intracerebral hemorrhage (ICH) after IV tPA treatment. In addition, four quality measures were also included: (1) time of door-to-needle (DTN) ≤60 minutes for patients who arrived <2 hours from symptom onset; (2) percentage of acute ischemic stroke patients that underwent IV tPA treatment; (3) frequency (%) of intra-arterial thrombolysis for all acute ischemic stroke patients; and (4) 30-day mortality for all stroke patients. For non-ambulatory patients, we did not include anticoagulant prophylaxis for deep venous thrombosis within 48 hours of admission as a quality measure, because symptomatic deep venous thrombosis is rare in immobilized patients including those with stroke in Asia [25]. Moreover, deep venous thrombosis only occurred in 0.2% of patients in the TSR study performed from 2006 to 2008 [22]. The topic of smoking cessation was included in stroke education. Symptomatic ICH after IV tPA treatment was defined as any ICH event documented by CT or MRI within 36 hours of IV tPA therapy, with National Institutes of Health Stroke Scale (NIHSS) deterioration of two or more points. DTN time ≤60 minutes were included because a decrease in the in-hospital delay can improve functional outcome after IV tPA treatment. In addition, the Target: Stroke initiative of the American Heart Association/American Stroke Association, proposed in 2011, aimed to achieve DTN time ≤60 minutes in more than 50% of patients [26].

Statistical analysis.

In Tables 1 and 2, categorical variables were presented as percentages, and either chi-square test or Fisher’s exact test, as appropriate, was used for comparisons between the two groups or study periods. Composite measures, similar to those reported in the GWTG-Stroke program in USA, were also derived based on five individual performance measures. The composite score was defined as the total number of interventions performed among eligible patients divided by the total number of possible interventions among eligible patients. In Table 3, the composite score reflects a summary score of performance of all five individual performance measures. However, the composite score comprises 11 performance measures except IA thrombolysis, symptomatic ICH after IV tPA, and 30-day mortality in Table 4. The multivariate linear regression model adjusting for hospital types was used to test the trends of quality measures and the composite score from 2006 to 2011 in Table 3 and quarterly composite performance measures in Table 4. Statistical significance was set at a two-sided p value <0.05. Analyses were performed using SAS statistical software version 9.1 (SAS Institute, Cary, NC).

Table 1. Quality Measures of 24 Hospitals Participating in BTS-Stroke Activity in 2010–2011.

Table 2. Comparison of Quality Measures from 14 Hospitals in Group I Before and During BTS-Stroke Activity and the GWTG-Stroke in USA (2003–2009).

Table 3. Trends of Quality Measures in 14 Hospitals in Group I Before and During BTS-Stroke Activity (2006–2011).

Table 4. Quarterly Composite Performance Measures of 24 Hospitals Participating in BTS-Stroke.


Data collected from 24 hospitals over a one-year period for 13,181 patients with acute ischemic stroke were analyzed. Fourteen of the 24 hospitals had been involved (to varying extents) in the TSR study conducted between 2006 and 2008, while 10 had not. Fifty percent of TSR hospitals (Group I) were medical centers and the median value of bed size was 664. Ninety percent of non-TSR hospitals (Group II) were regional hospitals and the median value of bed size was 600.5. The results of the stroke quality measures for all of the hospitals, as well as a comparison between the 14 TSR hospitals (n = 7,492) and the 10 non-TSR hospitals (n = 5,689) are shown in Table 1. Compared to non-TSR hospitals, TSR hospitals had a higher frequency of performing IA thrombolysis (0.9% vs. 0%, p = 0.008), more frequent prescriptions of oral anticoagulants for AF patients (64.1% vs. 48.0%, p<0.001), and more frequent prescriptions of lipid lowering drugs for patients with LDL ≥100 mg/dL (68.0% vs. 57.3%, p<0.001). In addition, rehabilitation evaluation (79.5% vs. 55.6%, p<0.001) and stroke education (94.9% vs. 88.5%, p<0.001) were more frequently used in TSR hospitals than that in non-TSR hospitals. However, DTN time ≤ 60 minutes were less frequent in TSR hospitals (50.8% vs. 56.7%, p = 0.008). The reason may be that half of TSR hospitals are medical centers, a DTN time ≤60 minutes may not be achievable in all ischemic stroke patients treated in medical centers, particularly those with unstable hemodynamics, respiratory compromise, or challenging clinical presentations.

For the 14 hospitals that participated in both the TSR study (2006–2008) and the present BTS-Stroke collaboration (2010–2011), a comparison of stroke quality measures was made between the two periods (Table 2). The results from the GWTG-Stroke program in USA are also listed for comparison. We found that most stroke quality measures were improved significantly. The rate of IV tPA use increased from 1.2% to 4.6% (p<0.001), DTN time ≤60 minutes improved from 7.1% to 50.8% (p<0.001), symptomatic hemorrhage after IV tPA decreased from 11.0% to 5.6% (p<0.001), anticoagulation treatment for AF increased from 32.1% to 64.1% (p<0.001), and lipid lowering drugs for LDL ≥100 mg/dL increased from 38.2% to 68% (p<0.001). The rates of IV tPA use, symptomatic ICH after IV tPA, early antithrombotics, antithrombotics at discharge during BTS -Stroke Activity were comparable to GWTG-Stroke in USA.

Yearly individual and composite measures of five stroke quality indicators, i.e. IV tPA <2 hours, early antithrombotic use, antithrombotic prescription at discharge, anticoagulation treatment for AF, and use of lipid lowering drugs for LDL ≥100 mg/dL, are shown in Table 3. Except for early antithrombotic use, significant improvements were observed for all measures and composite measures from 2006 to 2011. The percentage of IV tPA <2 hours dramatically improved from 18% to 77.6% between 2006 and 2011. The percentage of anticoagulation for AF raised from 34.7% to 63.9% and the use of lipid-lowering drug for LDL ≥ 100 mg/dL increased from 37.1% to 70.3%.

The quarterly changes in the composite scores of 11 performance measures—excluding intraarterial thrombolysis, symptomatic ICH after IV tPA, and 30-day mortality for all patients—are shown in Table 4 for the participating hospitals during the BTS-Stroke activity. A significant trend for overall quality improvement was found from 63.12 to 69.25 during the Q1-Q4 period (β = 2.00±0.85, p = 0.0203), particularly for non-TSR hospitals (β = 3.12±0.87, p = 0.0009).


The present study showed that quality of acute stroke care can be improved significantly after a well-organized, multi-center stroke quality improvement activity. The campaign activity described in this study was conducted through the BTS model introduced by the Institute for Healthcare Improvement in 1994 [23,24]. The BTS model has been implemented in previous studies of health-related topics. In the present study, we applied the BTS model in order to improve the quality of acute ischemic stroke care. The BTS activity consisted of three learning sessions and one final summative meeting. During each learning session, several multidisciplinary teams (each coming from separate institutions) met with each other, alongside subject experts, to communicate their experiences and to discuss the barriers they faced in their clinical practice. In this way, participants exchanged knowledge and reflected on strategies for improvement of the various measures. Associated with this one-year activity, improvement in 10 of 13 processes of acute ischemic stroke care was found, with highly significant improvements in thrombolytic therapy, dysphagia screening, anticoagulation treatment for AF, and prescription of lipid lowering drugs for LDL ≥100 mg/dL.

We put an emphasis on thrombolytic therapy for acute ischemic stroke patients because six of our 14 quality measures were related to thrombolytic therapy. Through the BTS-Stroke activity, the rate for IV tPA use was significantly increased with nearly four-fold from 1.2% in 2006–08 to 4.6% in 2010–11, which was equivalent to the GWTG-Stroke program. To highlight the importance of reducing the in-hospital delay for IV tPA administration, we selected DTN time ≤60 minutes as a quality measure. In the GWTG-Stroke program, less than 30% of acute ischemic stroke patients treated with IV tPA had DTN times ≤60 minutes (19.5% in 2003 to 29.1% in 2009) [27]. The guideline recommendation specifies that IV tPA treatment should be initiated within 60 minutes of arrival for acute ischemic patients (if there is no contraindication) [4]. During the BTS-Stroke learning sessions, hospitals with records of good performance for IV tPA use demonstrated best practice strategies to improve DTN time (consistent with the key strategies chosen by the Target: Stroke initiative) [26]. Many strategies, including pre-hospital notification, rapid triage, computerized stroke code, high priority of CT performance, and point-of-care testing, were widely adopted by the participating hospitals [26,2830]. The proportion of patients with DTN ≤60 minutes increased significantly from 7.1% in 2006–08 (before BTS) to 50.1% in 2010–11 (during BTS). This was accompanied by a decreased rate of symptomatic ICH (11.0% in 2006–08 to 5.6% in 2010–11).

Our previous TSR results also showed that only one-third of patients with AF were prescribed oral anticoagulants at discharge [22]. In a population study of AF patients in Taiwan, only 38.9% were in adherence with the 2006 American Heart Association/American College of Cardiology and the European Society of Cardiology (AHA/ACC/ESC) recommendations for antithrombotic therapy; among high risk patients, this was reduced to 24.4% (due in large part to underuse of oral anticoagulants) [31]. Both physicians and patients may have concerns regarding the increased risk of ICH associated with anticoagulants use; indeed, anticoagulants-related ICH was shown to occur more frequently in Asians than in other race/ethnicities (hazard ratio for ICH with whites as referent was 4.06 for Asians) [32]. However, through careful monitoring and frequent evaluation, these risks can be minimized. A computerized alarm reminder system for prescription at discharge was proposed by some hospitals as a way of improving adherence to quality measures. Due to the BTS-Stroke activity, the rate of oral anticoagulants use in eligible AF patients increased from 32.1% to 64.1%, which was still lower than that in the GWTG-Stroke program (91.1%) [33].

The risks of pneumonia and mortality are increased if acute stroke patients have dysphagia. Dysphagia screening can significantly decrease stroke-associated pneumonia, resulting in better functional outcomes [34,35]. Prior to this BTS activity, little formal dysphagia screening was being conducted in acute stroke patients in Taiwanese hospitals. In the TSR study from 2006 to 2008, only 5.6% patients were screened for swallowing function before their first oral intake. During the BTS-Stroke activity, one stroke nursing expert educated the participating teams on the necessity for dysphagia screening and provided details on its implementation [36]. Thereafter, adherence to dysphagia screening showed a marked improvement to 74.9%, similar to the GWTG-Stroke program (68.3%).

Taiwan is the first country outside of the United States to apply the quality measures of the GWTG-Stroke program, through evaluation of quality of acute stroke management in hospitals that participated in our previous TSR study [22]. The results highlighted a significant gap compared with the GWTG-Stroke program and guideline recommended targets for acute ischemic stroke patients were often suboptimal, especially in the areas of intravenous thrombolytic therapy, warfarin treatment for AF, and use of lipid lowering drugs for LDL ≥100 mg/dL. It is noteworthy that the purpose of TSR study was to establish a reliable stroke database for assessing acute stroke care quality and identifying areas that require improvement. There was no mandate from government for improvement in acute stoke care quality over time in TSR and quality improvement strategies were not included. While the Taiwan BTS-Stroke activity, conducted by the Taiwan Joint Commission on Hospital Accreditation, focus on the improvement of acute stroke care quality by group learning and competition in 2010. This is the reason why in Table 3, the significant trends of quality improvement for most indicators over the study period are attributed to the abrupt improvement between 2008 and 2010 rather than a gradual improvement. For hospitals participating in the TSR in 2006–2008, they were more familiar to their weak points in acute stoke care quality by reviewing their TSR data. Therefore they may improve quickly during the Q1 period in Taiwan BTS-Stroke activity. For non-TSR hospitals, the obvious improvements were observed during Q1-Q3 periods. These may partially explain the reason why the trend of improvement in composite performance measure during the BTS-activity for the hospitals participating in the previous TSR was not significant whereas it was significant among the hospitals without a previous experience of TSR in Table 4. A recent study reported successful adoption of GWTG-Stroke measures by a Brazilian tertiary hospital for quality improvement [37]. Several large-scale stroke registries that used stroke performance measures for quality evaluation indicated that systematic collection and evaluation of stroke performance measures can lead to rapid improvement in stroke care [38]. Our experience indicates that the BTS activity [23,24], – a multi-disciplinary, collaborative learning and feedback model—can further improve the quality of stroke care.

Our study has some limitations. Firstly, not all hospitals that participated in the previous TSR study were included in the present BTS-Stroke campaign activity (only 14 of the 39 TSR hospitals are represented in the present study). Nevertheless, this activity revealed many practical and effective strategies that can be transferred to other hospitals. The TSR continues to monitor the quality of acute stroke care according to the established quality measures. The Taiwan Joint Commission on Hospital Accreditation will implement the Taiwan Clinical Performance Indicator on stroke, mainly based on the BTS-Stroke quality measures. Secondly, the BTS-Stroke activity did not store data for individual patients, and only analyzed results for the performance of each hospital. Therefore, it was not possible to adjust for important variables such as age, sex, and stroke severity. However, we have compared performance before and during the BTS activity in the same set of 14 hospitals, which minimizes the unadjusted bias. Thirdly, this is an observational study without a contemporary control group. Thus it is not possible to fully attribute the improvement in measure performance solely to the BTS activity. However a prior analysis from the GWTG-Stroke program assessed the relationship of calendar time and time in the GWTG-Stroke quality improvement program and demonstrated an independent association between time participating in the program and measure improvement [18]. Fourthly, current stroke quality measures, including our own, are often confined to admissions of acute stroke cases and the associated process measures [38]. Revised quality measures for other types of stroke (e.g. hemorrhagic stroke) and measures for long-term care are also needed.

In conclusion, a BTS collaborative learning and campaign model can improve the guideline adherence for management of acute ischemic stroke. The GWTG-Stroke recommendations can be successfully conducted outside of the United States.


We would like to thank BTS-Stroke investigators for their help of data collection from each hospital.

List of BTS-Stroke Investigators

  1. National Taiwan University Hospital: Jiann-Shing Jeng, Sung-Chun Tang, Li-Kai Tsai, Chung-Hwa Chen, Kuang-Yu Huang, I-Chiann Deng, Ming-Ju Hsieh
  2. Buddhist Dalin Tzu Chi General Hospital: Yi-Kung Lee, Ming-Chin Hsu, Shan-Yun Chiu, Hui-Min Lee, Miao-Wen Chen, Ying-Mei Liu, Yu-Ling Wang
  3. Buddhist Tzu Chi General Hospital, Taipei Branch: Shinn-Kuang Lin, Cheng-Lun Hsiao, Fu-Yi Yang, Han-Lin Chiang, Yu-Chin Su, Chih-Yang Liu, Ser-Chen Fu
  4. Taipei Veterans General Hospital: Chang-Ming Chern, Wen-Jang Wong, Hui-Chi Huang, Su-Ju Yang, Ming-Zu Huang, Ching-Wei Lin, David Hung-Tsang Yen
  5. Kuang Tien General Hospital: Ming-Hui Sun, Yi-Hsiu Tsai, Yu-Fung Chang, Yu-Fen Chang, Li-Ru Chen, Suh-Er Guo, Chu-Han Chang
  6. Yuan's General Hospital: Hsien-An Cheng, Wei-Pang Huang, Kuo-Wei Hung, Shoou-Yang Lian, Hsing-Shui Hung, Yeh-Hsun Wu, Lin-Yung Kao
  7. Far Eastern Memorial Hospital: Siu-Pak Lee, Yuan-Hui Wu, Ching-Juing Yu, Hung-Ming Wu, Tzu-Hsien Lai, Cheng, Yin, Meng-Jung Shen
  8. Chi-Mei Medical Center: Huey-Juan Lin, Chun-Ming Yang, Ping-Jang Kuo, Chiao-Fang Chen, Chao-Hung Yeh, Chia-Yu Chang, Hung-Jung Lin
  9. Chang Gung Medical Hospital Linkou Branch: Tsong-Hai Lee, Yeu-Jhy Chang, Chien-Hung Chang, Ting-Yu Chang, Tai-Cheng Wu, Kuo-Lun Huang, Chi-Hung Liu
  10. Chi Mei Medical Center, Liouying: Ming-Hsiu Wu, Jyh-Jou Chen, Yu-Kang Chang, Ting-Hui Huang
  11. En Chu Kong Hosptial: Yu Sun, Chien-Jung Lu, Cheng-Huai Lin, Chang-Hsiu Liu, Chieh-Cheng Huang, Hoi Fong Chan, Pei-Fang Tsai
  12. Cheng Hsin General Hospital: Jiu-Haw Yin, Ta-Chang Lai, Chung-Jen Wang, Jong-Chyou Denq, Kai-Chen Wang, Li-Mei Chen, I-Chen Chiu
  13. Mackay Memorial Hospital: Helen L. Po, Ya-Ju Lin, Chao-Liang Chou, Shwu-Miaw Tsai, Hui-Fen Yu, Hui-Chen Hsu, Pi- Feng Hsieh
  14. Kaohsiung Municipal Hsiaokang Hospital: Shiang-Ru Lu, Chien-Fua Chen, Hui-Lin Lee, Hsin-Ling Chung, Ya-Fen Liu, Pei-Ling Tsai, Yu-Ling Hung
  15. Cathay General Hospital: Cheng-Hua Huang, Jen-Tse Chen, Yung-Lung Wu, Yung-Cheng Wang, Tung-Chou Li, Chih-Ju Chang, Pin-Wen Liao
  16. Keelung Chang Gung Memorial Hospital: Wei-Jie Weng, Su-E Ye, Li-Niang Ling, Li-Yuan Huang, Ling-Na Zhang, Feng-Jie Su
  17. Tungs’ Taichung Metro Harbor Hospital: Chi-Chiang Yang, Yen-Wen Lu, Qia-Zhou Yang, Hui-Jen Chen
  18. Shin Kong Wu Ho-Su Memorial Hospital: Li-Ming Lien, Hou-Chang Chiu, Tzong-Luen Wang, Sheng-Wen Hou, Hsu-Ling Yeh, Jui-Nan Cheng, Tsui-Hua Yang
  19. St. Martin De Porres Hospital: Chien-Chung Chen, Po-Yen Yeh, Ko-Yi Wang, Yu-Tai Tsai, Hung-Wen Chen, Wen-Huang Wang, Yu-Wen Tseng
  20. Ditamanson Medical Foundation Chia-Yi Christian Hospital: Sheng-Feng Sung, Yu-Hsiang Su, Li-Wei Wu, Ming-Yueh Chuang, Hui-Ju Tsai, Yi-Shan Lin, Shu-Min Hsu
  21. Chang Gung Memorial Hospital at Chiayi: Ying-Huang Tsai, Cheng-Ting Hsiao, Li-Yueh Hung, Yen-Chu Hung, Mei-Hsuen Chen, Po-Wen Shih, Cheng-Yen Lai
  22. Taipei City Hospital, Zhongxing Branch: Dachen Chu, Fang-Yuh Hsieh, Yiching Wu, Yen-Chen Chen, Lin Cheng-Yi Lin, Chan-Ming Yang, Chiu-Ju Chen
  23. Taipei Medical University-Shhuang Ho Hospital: Chaur-Jong Hu, Nai-Fang Chi, Le-Yan Lai, Shun-Tai Yang, Chi-Jen Chen, Jia-Huang Lin, Wuan-Jin Leu
  24. Landseed Hospital: Yu-Wei Chen, Kuo-Ying Lee, Chen-Hua Li, Yun-Yu Lin, Ying-Ying Lee, Shang-Hang Chen

Author Contributions

  1. Conceived and designed the experiments: JSJ LML KAL FIH HYC HCC HHL HC.
  2. Performed the experiments: JSJ CMC THL SCT LKT HJL LML.
  3. Analyzed the data: FIH JSJ.
  4. Contributed reagents/materials/analysis tools: JSJ FIH CMC THL SCT LKT HJL LML.
  5. Wrote the paper: FIH JSJ LML.


  1. 1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007; 6: 182–187. pmid:17239805
  2. 2. Lee HY, Hwang JS, Jeng JS, Wang JD. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up. Stroke. 2010; 41: 739–744. pmid:20150543
  3. 3. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011; 124: 314–323. pmid:21730306
  4. 4. Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44: 870–947. pmid:23370205
  5. 5. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42: 227–276. pmid:20966421
  6. 6. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25: 457–507. pmid:18477843
  7. 7. Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, et al. II. Cerebral infarction/transient ischemic attack (TIA). J Stroke Cerebrovasc Dis. 2011; 20: S31–73. pmid:21835356
  8. 8. Johnston SC, Nguyen-Huynh MN, Schwarz ME, Fuller K, Williams CE, Josephson SA, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol. 2006; 60: 301–313. pmid:16912978
  9. 9. Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006; 354: 1147–1156. pmid:16540615
  10. 10. Scholte op Reimer WJ, Dippel DW, Franke CL, van Oostenbrugge RJ, de Jong G, Hoeks S, et al. Quality of hospital and outpatient care after stroke or transient ischemic attack: insights from a stroke survey in the Netherlands. Stroke. 2006; 37: 1844–1849. pmid:16728690
  11. 11. Saposnik G, Goodman SG, Leiter LA, Yan RT, Fitchett DH, Bayer NH, et al. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke. 2009; 40: 1417–1424. pmid:19213947
  12. 12. Dippel DW, Simoons ML. Improving adherence to guidelines for acute stroke management. Circulation. 2009; 119: 16–18. pmid:19103985
  13. 13. Parker C, Schwamm LH, Fonarow GC, Smith EE, Reeves MJ. Stroke quality metrics: systematic reviews of the relationships to patient-centered outcomes and impact of public reporting. Stroke. 2012; 43: 155–162. pmid:21980213
  14. 14. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. Jama. 2000; 283: 3102–3109. pmid:10865305
  15. 15. Leifer D, Bravata DM, Connors JJ 3rd, Hinchey JA, Jauch EC, Johnston SC, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42: 849–877. pmid:21233469
  16. 16. George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, et al. Paul Coverdell National Acute Stroke Registry Surveillance—four states, 2005–2007. MMWR Surveill Summ. 2009; 58: 1–23.
  17. 17. LaBresh KA, Reeves MJ, Frankel MR, Albright D, Schwamm LH. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. Arch Intern Med. 2008; 168: 411–417. pmid:18299497
  18. 18. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009; 119: 107–115. pmid:19075103
  19. 19. Ingeman A, Pedersen L, Hundborg HH, Petersen P, Zielke S, Mainz J, et al. Quality of care and mortality among patients with stroke: a nationwide follow-up study. Med Care. 2008; 46: 63–69. pmid:18162857
  20. 20. Lingsma HF, Dippel DW, Hoeks SE, Steyerberg EW, Franke CL, van Oostenbrugge RJ, et al. Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey. J Neurol Neurosurg Psychiatry. 2008; 79: 888–894. pmid:18208861
  21. 21. Abilleira S, Ribera A, Sanchez E, Tresserras R, Gallofre M. The Second Stroke Audit of Catalonia shows improvements in many, but not all quality indicators. Int J Stroke. 2012; 7: 19–24. pmid:21967542
  22. 22. Hsieh FI, Lien LM, Chen ST, Bai CH, Sun MC, Tseng HP, et al. Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan. Circulation. 2010; 122: 1116–1123. pmid:20805428
  23. 23. The Breakthrough Series: IHI’s Collaborative Model for Achieving Breakthrough Improvement. IHI Innovation Series white paper. Boston: Institute for Healthcare Improvement. 2003. Available:
  24. 24. Institute for Healthcare Improvement. The Breakthrough Series: IHI’s Collaborative model for achieving breakthrough improvement. Diabetes Spectrum. 2004; 17: 97–101.
  25. 25. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med. 2007; 13: 377–383. pmid:17940480
  26. 26. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011; 42: 2983–2989. pmid:21885841
  27. 27. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011; 123: 750–758. pmid:21311083
  28. 28. Heo JH, Kim YD, Nam HS, Hong KS, Ahn SH, Cho HJ, et al. A computerized in-hospital alert system for thrombolysis in acute stroke. Stroke. 2010; 41: 1978–1983. pmid:20651269
  29. 29. Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2012; 5: 514–522. pmid:22787065
  30. 30. Rizos T, Herweh C, Jenetzky E, Lichy C, Ringleb PA, Hacke W, et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke. 2009; 40: 3547–3551. pmid:19696414
  31. 31. Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH, et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation—a nationwide descriptive study in Taiwan. Clin Ther. 2008; 30: 1726–1736. pmid:18840379
  32. 32. Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007; 50: 309–315. pmid:17659197
  33. 33. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes. 2010; 3: 291–302. pmid:20177051
  34. 34. Carnaby G, Hankey GJ, Pizzi J. Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol. 2006; 5: 31–37. pmid:16361020
  35. 35. Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011; 378: 1699–1706. pmid:21996470
  36. 36. Yeh SJ, Huang KY, Wang TG, Chen YC, Chen CH, Tang SC, et al. Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit. J Neurol Sci. 2011; 306: 38–41. pmid:21549394
  37. 37. de Carvalho FA, Schwamm LH, Kuster GW, Bueno Alves M, Cendoroglo Neto M, Sampaio Silva G, et al. Get with the guidelines stroke performance indicators in a brazilian tertiary hospital. Cerebrovasc Dis Extra. 2012; 2: 26–35. pmid:22811686
  38. 38. Reeves MJ, Parker C, Fonarow GC, Smith EE, Schwamm LH. Development of stroke performance measures: definitions, methods, and current measures. Stroke. 2010; 41: 1573–1578. pmid:20489174